Akrevia Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- September 27, 2018
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $30,000,000
Company Info
- Company Description
- Akrevia Therapeutics is a privately-held biopharmaceutical company focused on developing highly-potent, targeted immuno-oncology therapeutics. The company's proprietary Aklusion platform technology allows biologics to be specifically activated in the tumor microenvironment, and with precisely tailored properties, expanding the universe of immune-activating proteins that can be safely delivered.
- Market
- Immuno-oncology therapeutics
- Location
- Cambridge, MA, USA
- Coinvestors
- Atlas Venture, F-Prime Capital Partners